ONCOCYTE CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.74 USD | +3.40% |
|
-3.18% | +9.60% |
| May. 30 | Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results | CI |
| May. 15 | Transcript : OncoCyte Corporation, Q1 2024 Earnings Call, May 15, 2024 |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- OCX Stock
- Revisions OncoCyte Corporation
